Toward Greater Scientific Rigor

Similar documents
August 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center

Quality Assurance and Regulatory Compliance Office and USAMRIID FDA Risk Management. Carolyn Mentzer Chief, QARCO

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016

KL2 Mentored Career Development Grant

Effective Date: April 2014 Revision: September 29, Executive Chair, Co-Chairs, NSHA REB Members, REB Office Personnel, Researchers.

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Good Clinical Practice: A Ground Level View

managing or activities.

Why do we need an addendum to ICH E6?

The GCP Perspective on Study Monitoring

Overview ICH GCP E6(R2) Integrated Addendum

Resource Document for IRB members

12.0 Investigator Responsibilities

Good Documentation Practices. Human Subject Research. for

Office of the Vice Chancellor for Research Supervisory Responsibilities of Clinical Investigators

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Clinical Trial Quality Assurance Common Findings

CTN POLICIES AND PROCEDURES GUIDE

1. INTRODUCTION 2. SCOPE 3. PROCESS

PMDA EPOCH Toward 2020

Clinical Research Professionals

Standard Operating Procedures

MENTORED CAREER DEVELOPMENT (KL2) AWARD REQUEST FOR PROPOSALS

Session 3 FDA Audits and Findings

Computer Validation Initiative Committee Membership Requirements

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Research Involving Human Subjects NIH Regional Seminar

APEC Preliminary Workshop: Review of Drug Development in Clinical Trials

Janssen Policy Evaluating and Responding to Pre-approval Access Requests for Investigational Medicines

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

Training components for GCP. inspectors in PMDA. Tomonori Tateishi, MD, PhD Office of Conformity Audit, PMDA

Investigator Roles and Responsibilities in Clinical Device Trials

Training, Site Selection and Human Subject Protection: Factors to Consider When Developing a Monitoring Plan

1. Department of Defense (DoD) Human Subjects Protection Regulatory Requirements

Risk Assessment and Monitoring

FDA Medical Device Regulations vs. ISO 14155

University of California, San Diego Human Research Protections Program Institutional Review Board Standard Operating Policies and Procedures

NANCI A. HAYWARD North Springs Drive Dunwoody, Georgia

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

*Applicable to: Beaumont Health. Document Type: Policy

Solutions for GCP Compliance Challenges. September 23, 2015 Northwestern University IRB Brown Bag Session

Solutions for GCP Compliance Challenges

Revised: August 2017 Effective: 6 September 2017 TABLE OF CONTENTS

LOUIS STOKES CLEVELAND VA MEDICAL CENTER RESEARCH SERVICE Human Subject Protection Standard Operating Procedure (SOP)

Quality Assurance and Site Monitoring Visits. Introduction. Training Outline

Training & Resources for Clinical Research Professionals

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Audits/Inspections Be Prepared for Anything

Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards

University of Virginia Standard Operating Procedures for the Human Research Protection Program

New European Union Clinical Trial Regulations

Institutional Review Board Standard Operating Procedures. Education and Training on Human Subject Research Date Last Revised: OVERVIEW

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Addendum to ICH E6 (R2)

Preparing for and responding to an FDA Inspection Frank Estala Kathy James Clara Vorpahl Anna Taranova

Margaret Huber, RN, CHRC Compliance Consultant Office of Research Compliance

Overview of the IMB s. Good Clinical Practice. Deirdre O Regan GCP/Pharmacovigilance. GCP Seminar Dublin, 27 th January 2010.

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

ICH Regulators Forum. Dr Peter Arlett EU

EMA & FDA Inspections: Site perspective. Shandukani Research Centre

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Joint R&D Support Office SOP S-2011 UHL

SECTION 2: REGISTER YOUR ICU

ISO14155: 2011 Clinical investigation of medical devices for human subjects - Good Clinical Practice - ISO TC194 WG4 Madoka Murakami PMDA, Japan

I. Scope This policy defines unanticipated problems and adverse events and establishes the reporting process and timeline.

Unofficial copy not valid

CLOSEOUT - DON T SHUT DOWN SRA 2018 NORTHEAST/WESTERN SECTION MEETING MARCH 2018

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-D

Office of Human Research Ethics/IRB Standard Operating Procedures

Reporting to the IRB How to Report the Essentials and Improve the Protection of Human Subjects

3 HPTN OPERATIONAL COMPONENTS

Prepared by the American College of Radiology Imaging Network Protocol Development and Regulatory Compliance Department

16 STUDY OVERSIGHT Clinical Quality Management Plans

Forward looking approaches & its Experiences of PMDA's ATC

Patti Manheim, Director April 11, 2013

Connie Hoy October 2013

Tomoko OSAWA, Ph.D. Director for GCP Inspection Office of Conformity Audit PMDA, Japan

Harrison Clinical Research. Monitoring of Clinical Trials - Quality Management from a CRO s Perspective

Vertex Investigator-Initiated Studies Program Overview

Preliminary Questionnaire

Clinical Research Seminar

SAINT AGNES MEDICAL CENTER CLINICAL RESEARCH CENTER Fresno, California. STANDARD OPERATING PROCEDURES Institutional Review Board

Roles & Responsibilities of Investigator & IRB

Research Staff Training

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

UConn Health Office of Clinical & Translational Research Standard Operating Procedures

Standard Operating Procedures (SOP) Research and Development Office

Standard Operating Procedures

Subject Research Records. Essential Regulatory and Source Documents. Subject Research Records. Regulatory Files

Checklist prior to recruiting first patient

STANDARD OPERATING PROCEDURE

EMORY UNIVERSITY INSTITUTIONAL REVIEW BOARD POLICIES AND PROCEDURES 7/01/2016

Human Subjects Research Policy Update. Naomi Coll Director of Research Policy and Compliance

Title: Investigator Responsibilities. SOP Number: 1501 Effective Date: June 2, 2017

Clarification on Salary Supplementation and Compensation During Entire Period of K Award

Transcription:

Toward Greater Scientific Rigor Good Clinical Practice (GCP) A NEW REQUIREMENT! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork

The requirement: NIH: NOT-OD-16-148 Policy of Good Clinical Practice Training for NIH Awardees Involved in NIH-Funded Clinical Trials https://grants.nih.gov/grants/guide/notice-files/not-od-16-148.html

New initiatives to ensure rigor and efficiency in clinical trials Re-engineer DESIGN: the process by which clinical investigators develop ideas for new trials, CONDUCT: how NIH reviews and selects clinical trials for support and oversees the progress of the research, and REPORTING: how results and aggregate data are shared broadly and rapidly.

RIGOR: Requiring GCP training GCPs provide a consistent and high quality standard for conducting research. All NIH-funded investigators and staff involved in the conduct, oversight, or management of clinical trials should be trained in Good Clinical Practice (GCP), consistent with principles of the International Conference on Harmonization (ICH) E6 (R2). The principles of GCP help assure the safety, integrity, and quality of clinical trials. GCPs provide a standard for ensuring Describes clinical trial compliance, implementation, data collection, monitoring, and reporting Outlines the responsibilities of Institutional Review Boards (IRBs), investigators, sponsors and monitors. Addresses elements related to the design, conduct and reporting of clinical trials.

BUT what are GCPs? Simply put, they provide guidelines: to assure the rights of study subjects are protected in research. to assure the accurate and reliable collection of data in research.

International Conference on Harmonization Good Clinical Practices The principles were developed in 1996 with representatives from the European Union, Japan, and the United States. Describes the responsibilities of investigators, sponsors, monitors and IRBs. NOT the same as IRB training (which became a requirement in June 2000.

What NOT-OD-16-148 says: Scope and Applicability This Policy applies to NIH-funded investigators and clinical trial site staff who are responsible for the conduct, management and oversight of NIH-funded clinical trials. GCP training includes the Principles of ICH GCP found in Section 2 of ICH E6. GCP training may be achieved through a class or course, academic training program, or certification from a recognized clinical research professional organization. GCP training should be refreshed at least every three years in order remain current with regulations, standards and guidelines. Investigator: The individual responsible for the conduct of the clinical trial at a trial site. Clinical trial staff: Individuals, identified by the investigator, who are responsible for study coordination, data collection and data management. The central focus of clinical trial staff is to manage participant recruitment and enrollment, to maintain consistent study implementation, data management, and to ensure integrity and compliance with regulatory and reporting requirements.

(ICH) E6 (R2) pending updates. Pending changes implemented to ICH GCP E6 (R2) in 2016: Oversight: increased requirement for investigators when third party involved, and more sponsor oversight of CRO/monitor. Technology: Data security (mirrors 21 CFR 11). Significant non-compliance: CAPA correction and preventive action. Risk Management: requiring quality management system and Risk Based Monitoring.

SOOO where is the training and how will we know we are compliant? Basic course: Miami CITI ICH-GCP training http://www.uab.edu/research/administration/offices/irb/training/pages/ichgcp-training.aspx Enhanced courses: Research Orientation Program (monthly everyone) Research Coordinator Training Program (twice a year staff) Clinical Investigator Training Program (in development) Research Seminar (2 offerings monthly) Others to come

Requiring GCP training is a first step While GCP training on its own may not be sufficient, it provides consistent and high quality standards which should be followed. Release date: 16 September 2016 Effective date: 1 January 2017

I am not doing NIH funded Clinical Trials, so why do I need to do this? ALL human research, whether locally funded or industry sponsored, ethically require that the same standards: Provide guidelines to assure the rights of study subjects are protected in research. Provide guidelines to assure the accurate and reliable collection of data in research.

Top 10 GCP issues on FDA 483s (FDA warning letter) http://compliance-insight.com/fda-483-warning-letters/top-ten-reasons-for-fda-483/ CFR Reference Frequency Description #1 21 CFR 211.22(d) 169 Procedures not in writing, fully followed #2 21 CFR 211.192 119 Investigations of discrepancies, failures #3 21 CFR 211.100(a) 116 Absence of Written Procedures #4 21 CFR 211.160(b) 115 Scientifically sound laboratory controls #5 21 CFR 211.110(a) 89 Control procedures to monitor and validate performance #6 21 CFR 211.67(b) 73 Written procedures not established/followed #7 21 CFR 211.68(a) 69 Calibration/Inspection/Checking not done #8 21 CFR 211.25(a) 65 Training operations, GMPs, written procedures #9 21 CFR 211.67(a) 65 Cleaning / Sanitizing / Maintenance #10 21 CFR 211.100(b) 64 SOPs not followed / documented

Questions? 205.934.7442 ccts@uab.edu www.uab.edu/ccts 1924 7 th Ave. S UAB Campus - PCAMS Thank you to our Partners! The Center for Clinical & Translational Science 205.934.7442 ccts@uab.edu www.uab.edu/ccts @cctsnetwork